IN DETAIL

Christie is pleased to announce the launch of the Christie CounterAct line of commercial UV disinfection products with patented Care222 far-UVC light technology for cinemas, theme parks, museums, sports complexes and other indoor spaces. The Christie fixture uses Ushio’s patented narrowband filtered Care222 excimer lamps that emit far-UVC 222nm light - the only UV technology shown to continuously and significantly reduce pathogens, like coronaviruses, that may also be used while people are present, when used in accordance with specified parameters. Mass production of the new Christie CounterAct fixture starts in January 2021. Developed by Christie’s parent company, Ushio Inc., based on technology licensed from Columbia University, the revolutionary Care222 far-UVC, mercury-free excimer lamp includes a proprietary short pass filter that prevents the emission of longer wavelengths of UV light (230nm and

higher) that are capable of penetrating human skin and eyes, an especially important feature that other 222nm and far-UVC products do not have. It has been known for many years that UV light is a highly effective disinfectant that can reduce pathogens in indoor spaces. Businesses and other institutions have long used germicidal UVC light to stop the spread of viruses. The main drawback with most UVC technology is that it uses a 254nm wavelength that can penetrate human skin and eyes, which means these germicidal lights can only be used when people are not present or while they’re wearing personal protective equipment (PPE) that protects the eyes and skin. These shortcomings constrain how these devices must be operated and limit their widespread use in occupied indoor spaces. A study conducted by Kobe University published in August 2020 concludes that, due to its shorter wavelength, far-UVC 222nm light does not penetrate the skin and therefore may be used when humans are present. Researchers at Columbia University Irving Medical Center have also tested far-UVC 222nm light, and in particular its effect on aerosolised seasonal coronaviruses (that cause the common cold). A scientific paper published by this group in the journal Nature in June 2020 found that 99.9% of aerosolised seasonal coronaviruses (the cause of the common cold) were inactivated when exposed to far-UVC 222nm light in just 25 minutes. These studies’ findings suggest that the filtered 222nm far-UVC light emitted by Care222 lamps in Christie’s CounterAct fixture, which can operate continuously even when people are present, offers a significant improvement over traditional manual cleaning alone, which requires professional cleaners, and the repeated use of harsh chemicals, in which the results are temporary. www.christiedigital.com/commercial-uv-disinfection

QSC has Introduced two new Q-SYS Core processors: CORE 8 FLEX & NANO. The perfect size for those smaller applications across corporate, higher education, healthcare and beyond, with the same rock-solid processing power and extensibility you have come to expect. These processors are designed for applications with lower network channel capacity and/or targeted processing requirements. Built on the same foundational technology as the rest of the Q-SYS processor portfolio, including the best-in-class Q-SYS Core 110f, Core 8 Flex

is designed for applications with lower network or analog channel capacity and/or targeted processing requirements. Some of the feautres and benefits include: • Full-featured audio, video & control processing power and extensibility you have come to expect from the Q-SYS Ecosystem. • Optimised for QSC Conferencing needs allowing for full room web conference integration, particularly for high value, specialty rooms. • Same software (Q-SYS Designer Software) for the entire Ecosystem; scale-up or scale-out with ease. The Q-SYS Core 8 Flex is ideal for single room, distributed processing with analog & networked endpoints, the Core 8 Flex audio, video and control (AV&C) processor extends the applications of the Q-SYS Ecosystem. The Q-SYS Core Nano is perfect for multiroom with centralised processing and network endpoints. www.qsc.com

Two new loudspeakers are joining the Pioneer Professional Audio XY Series: the XY-1 and XY-2E. Developed to allow more versatile use of its flagship XY-3B, the XY-1 and XY-2E represent the LF and MHF sections respectively and each unit is available in black. Using these individual enclosures enables installers, rental houses and touring companies to easily build ground stacked point-source arrays and deploy systems in venues with low ceilings via a wide variety of configurations. XY Series loudspeakers provide excellent reliability and outstanding audio quality to nightclubs and music venues around the world. In September 2017, Pioneer introduced the XY-3B and XY-2, which incorporate its X-Phase system. And now, with the release of the XY-1 and XY-2E, even more venues and events can benefit from the

performance of an XY Series sound system due to the horizontal-array deployment options offered by the new units. The XY-1 consists of two 12-inch custom drivers in a hybrid dual-chamber configuration - exactly the same as the XY-3B, maintaining the chestpumping low end of the flagship model. The XY-2E is much more than an XY-2 in an enclosure. Pioneer have kept the X-phase system, but enabled individual control of the eight-inch cone driver and one-inch compression driver, which wasn’t previously possible. These adaptable new additions to the XY Series can also be used as stage fills, for live PA and DJ booth monitoring, thanks to the tailor-made accessories that make them easy to deploy in tight spaces. www.pioneerproaudio.com